North America & Europe Epilepsy Market Research Report Information Forecast to 2032 Based on Condition (Generalized Epilepsy and Focal Epilepsy), By diagnosis & treatment, By End User (hospitals & clinics, diagnostic centers, and others), By Region (US, C
North America & Europe Epilepsy Market Research Report Information Forecast to 2032 By Condition (Generalized Epilepsy and Focal Epilepsy), By diagnosis & treatment, By End User (hospitals & clinics, diagnostic centers, and others), By Region (US, Canada, Europe)
It is projected that the epilepsy market in North America and Europe would increase at a strong rate throughout the study period, with a compound annual growth rate of 8.18%. Recurrent seizures are a common symptom of epilepsy, a persistent neurological illness that damages the brain. Uncontrolled electrical activity in the brain, or seizures, can alter behavior, consciousness, movement, and sensation.
Growth in the epilepsy market in North America and Europe is mostly due to rising knowledge and understanding of the condition, as well as rising occurrences of epilepsy in these regions. Nonetheless, it is anticipated that the adverse effects of antiepileptic medications will limit the epilepsy market's expansion in North America and Europe. However, growing clinical trials for items used in epilepsy diagnosis and treatment research, as well as increased investment in these areas, are expected to open profitable potential for the market.
Market Segmentation
Generalized epilepsy and focal epilepsy are the two categories into which the epilepsy markets in North America and Europe have been divided.
The epilepsy market in North America and Europe is divided into two segments: diagnosis and therapy.
The market has been divided into hospitals and clinics, diagnostic centers, and other end users.
Growth at a compound annual growth rate (CAGR) of 7.88% is anticipated in the North American epilepsy market, which was valued at USD 6,888.72 million in 2022. The US and Canada are two more divisions of North America.
Important Players
Leading companies in the market include Sun Pharmaceutical Industries Ltd., UCB S. A., H. Lundbeck A/S., Johnson & Johnson Services, Inc., Novartis AG, GlaxoSmithKline, Boston Scientific Corporation, Abbott, Cipla Ltd., and Eisai Co., Ltd.
1 Executive Summary
2 Market Introduction
2.1 Definition
2.2 Scope Of The Study
2.3 Research Objective
2.4 Market Structure
3 Research Methodology
3.1 Overview
3.2 Data Flow
3.2.1 Data Mining Process
3.3 Purchased Database:
3.4 Secondary Sources:
3.4.1 Secondary Research Data Flow:
3.5 Primary Research:
3.5.1 Primary Research Data Flow:
3.5.2 Primary Research: Number Of Interviews Conducted
3.6 Approaches For Market Size Estimation:
3.6.1 Revenue Analysis Approach
3.7 Data Forecasting
3.7.1 Data Forecasting Type
3.8 Data Modeling
3.8.1 Microeconomic Factor Analysis:
3.8.2 Data Modeling:
3.9 Teams And Analyst Contribution
4 Market Dynamics
4.1 Introduction
4.2 Drivers
4.2.1 Increasing Incidences Of Epilepsy In North America And Europe Region
4.2.2 Rising Awareness And Understanding Of Epilepsy
4.3 Restraints
4.3.1 Side Effects Associated With Antiepileptic Drugs
4.4 Opportunity
4.4.1 Increasing Investment For Epilepsy Diagnosis & Treatment Research
4.4.2 Growing Clinical Trials For Epilepsy Treatment Products
5 Market Factor Analysis
5.1 Porter's Five Forces Model
5.1.1 Threat Of New Entrants
5.1.2 Bargaining Power Of Suppliers
5.1.3 Threat Of Substitutes
5.1.4 Bargaining Power Of Buyers
5.1.5 Intensity Of Rivalry
5.2 Impact Of Covid-19 On The North America And Europe Epilepsy Market
5.3 R&D Investment By Major Pharmaceutical And Medical Device Companies On Epilepsy
5.4 List Of Failed Clinical Trials For Epilepsy Drug
5.5 Clinical Trial Landscape For Epilepsy Drugs And Devices
5.6 Current Trends On Seeg Procedures
5.7 Qualitative Overview On Epilepsy Treatment Management Other Than Drugs And Surgery
6 North America And Europe Epilepsy Market, By Condition
6.1 Overview
6.2 Generalized Epilepsy
6.3 Focal Epilepsy
7 North America And Europe Epilepsy Market, By Diagnosis & Treatment
7.1 Overview
7.2 Diagnosis
7.2.1 Blood Tests
7.2.2 Electroencephalogram (Eeg) Imaging Test
7.2.3 Imaging Scan
7.2.3.1 Magnetic Resonance Imaging (Mri) Scan
7.2.3.2 Computerized Tomography (Ct) Scan
7.2.3.3 Others
7.3 Treatment
7.3.1 Drug Class
7.3.1.1 First Generation Anti-epileptic Drugs
7.3.1.2 Second Generation Anti-epileptic Drugs
7.3.1.3 Third Generation Anti-epileptic Drugs
7.3.2 Surgery
7.3.2.1 Focal Resection
7.3.2.2 Lesionectomy
7.3.2.3 Corpus Callosotomy
7.3.2.4 Others
7.3.3 Therapies
7.3.3.1 Vagus Nerve Stimulation
7.3.3.2 Deep Brain Stimulation
7.3.3.3 Responsive Neurostimulation
7.3.3.4 Thermocoagulation
8 North America And Europe Epilepsy Market, By End User
8.1 Overview
8.2 Hospitals And Clinics
8.3 Diagnostic Centers
8.4 Others
9 North America & Europe Epilepsy Market, By Region
9.1 North America
9.1.1 Us
9.1.2 Canada
9.2 Europe
9.2.1 Germany
9.2.2 France
9.2.3 Uk
9.2.4 Italy
9.2.5 Spain
9.2.6 Rest Of Europe
10 Competitive Landscape
10.1 Introduction
10.2 Market Share Analysis, 2022
10.3 Competitor Dashboard
10.4 Public Players Stock Summary
10.5 Comparative Analysis: Key Players Finanical
10.6 Key Developments & Growth Strategies
10.6.1 Product Launch / Product Approval
10.6.2 Acquisition
11 Company Profiles
11.1 Johnson & Johnson Services, Inc.
11.1.1 Company Overview
11.1.2 Financial Overview
11.1.3 Products Offered
11.1.4 Key Developments
11.1.5 Swot Analysis
11.1.6 Key Strategy
11.2 Boston Scientific Corporation
11.2.1 Company Overview
11.2.2 Financial Overview
11.2.3 Products Offered
11.2.4 Key Developments
11.2.5 Swot Analysis
11.2.6 Key Strategies
11.3 Abbott
11.3.1 Company Overview
11.3.2 Financial Overview
11.3.3 Products Offered
11.3.4 Key Developments
11.3.5 Swot Analysis
11.3.6 Key Strategies
11.4 Cipla Ltd
11.4.1 Company Overview
11.4.2 Financial Overview
11.4.3 Products Offered
11.4.4 Key Developments
11.4.5 Swot Analysis
11.4.6 Key Strategies
11.5 Ucb S.A
11.5.1 Company Overview
11.5.2 Financial Overview
11.5.3 Products Offered
11.5.4 Key Developments
11.5.5 Key Strategies
11.6 H. Lundbeck A/S
11.6.1 Company Overview
11.6.2 Financial Overview
11.6.3 Products Offered
11.6.4 Key Developments
11.6.5 Key Strategies
11.7 Eisai Co., Ltd
11.7.1 Company Overview
11.7.2 Financial Overview
11.7.3 Products Offered
11.7.4 Key Developments
11.7.5 Key Strategies
11.8 Novartis Ag
11.8.1 Company Overview
11.8.2 Financial Overview
11.8.3 Products Offered
11.8.4 Key Developments
11.8.5 Swot Analysis
11.8.6 Key Strategies
11.9 Glaxosmithkline Plc
11.9.1 Company Overview
11.9.2 Financial Overview
11.9.3 Products Offered
11.9.4 Key Developments
11.9.5 Key Strategies
11.10 Sun Pharmaceutical Industries Limited
11.10.1 Company Overview
11.10.2 Financial Overview
11.10.3 Products Offered
11.10.4 Key Developments
11.10.5 Key Strategies
List Of Tables
Table 1 Qfd Modeling For Market Share Assessment
Table 2 R&D Investment By Major Pharmaceutical And Medical Device Companies On Epilepsy
Table 3 List Of Failed Clinical Trials For Epilepsy Drug
Table 4 North America And Europe Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 5 North America And Europe Epilepsy Market, For Generalized Epilepsy, By Region, 2019–2032 (Usd Million)
Table 6 North America And Europe Epilepsy Market, For Focal Epilepsy, By Region, 2019–2032 (Usd Million)
Table 7 North America And Europe Epilepsy Market, Diagnosis & Treatment Segment Attractiveness, 2022-2032 (Usd Million)
Table 8 North America And Europe Epilepsy Market, By Diagnosis & Treatment, 2019–2032 (Usd Million)
Table 9 North America And Europe Epilepsy Market, For Diagnosis, By Region, 2019–2032 (Usd Million)
Table 10 North America And Europe Epilepsy Market, For Diagnosis, By Type, 2019–2032 (Usd Million)
Table 11 North America And Europe Epilepsy Market, For Blood Tests, By Region, 2019–2032 (Usd Million)
Table 12 North America And Europe Epilepsy Market, For Electroencephalogram (Eeg) Imaging Test, By Region, 2019–2032 (Usd Million)
Table 13 North America And Europe Epilepsy Market, For Imaging Scan, By Region, 2019–2032 (Usd Million)
Table 14 North America And Europe Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Usd Million)
Table 15 North America And Europe Epilepsy Market, For Magnetic Resonance Imaging (Mri) Scan, By Region, 2019–2032 (Usd Million)
Table 16 North America And Europe Epilepsy Market, For Computerized Tomography (Ct) Scan, By Region, 2019–2032 (Usd Million)
Table 17 North America And Europe Epilepsy Market, For Others, By Region, 2019–2032 (Usd Million)
Table 18 North America And Europe Epilepsy Market, For Treatment, By Region, 2019–2032 (Usd Million)
Table 19 North America And Europe Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 20 North America And Europe Epilepsy Market, For Drug Class, By Region, 2019–2032 (Usd Million)
Table 21 North America And Europe Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 22 North America And Europe Epilepsy Market, For First Generation Anti-epileptic Drugs, By Region, 2019–2032 (Usd Million)
Table 23 North America And Europe Epilepsy Market, For Second Generation Anti-epileptic Drugs, By Region, 2019–2032 (Usd Million)
Table 24 North America And Europe Epilepsy Market, For Third Generation Anti-epileptic Drugs, By Region, 2019–2032 (Usd Million)
Table 25 North America And Europe Epilepsy Market, For Surgery, By Region, 2019–2032 (Usd Million)
Table 26 North America And Europe Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 27 North America And Europe Epilepsy Market, For Focal Resection, By Region, 2019–2032 (Usd Million)
Table 28 North America And Europe Epilepsy Market, For Lesionectomy, By Region, 2019–2032 (Usd Million)
Table 29 North America And Europe Epilepsy Market, For Corpus Callosotomy, By Region, 2019–2032 (Usd Million)
Table 30 North America And Europe Epilepsy Market, For Others, By Region, 2019–2032 (Usd Million)
Table 31 North America And Europe Epilepsy Market, For Therapies, By Region, 2019–2032 (Usd Million)
Table 32 North America And Europe Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 33 North America And Europe Epilepsy Market, For Vagus Nerve Stimulation, By Region, 2019–2032 (Usd Million)
Table 34 North America And Europe Epilepsy Market, For Deep Brain Stimulation, By Region, 2019–2032 (Usd Million)
Table 35 North America And Europe Epilepsy Market, For Responsive Neurostimulation, By Region, 2019–2032 (Usd Million)
Table 36 North America And Europe Epilepsy Market, For Thermocoagulation, By Region, 2019–2032 (Usd Million)
Table 37 North America And Europe Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 38 North America And Europe Epilepsy Market, For Hospitals And Clinics, By Region, 2019–2032 (Usd Million)
Table 39 North America And Europe Epilepsy Market, For Diagnostic Centers, By Region, 2019–2032 (Usd Million)
Table 40 North America And Europe Epilepsy Market, For Others, By Region, 2019–2032 (Usd Million)
Table 41 North America: Epilepsy Market, By Country, 2019–2032 (Usd Million)
Table 42 North America: Epilepsy Market, By Condition, 2019–2032 (Usd Million)
Table 43 North America: Epilepsy Market, By Diagnosis & Treatment, 2019-2032 (Usd Million)
Table 44 North America: Epilepsy Market, For Diagnosis, By Type, 2019-2032 (Usd Million)
Table 45 North America: Epilepsy Market, For Imaging Scan, By Type, 2019–2032 (Usd Million)
Table 46 North America: Epilepsy Market, For Treatment, By Type, 2019–2032 (Usd Million)
Table 47 North America: Epilepsy Market, For Drug Class, By Type, 2019–2032 (Usd Million)
Table 48 North America: Epilepsy Market, For Surgery, By Type, 2019–2032 (Usd Million)
Table 49 North America: Epilepsy Market, For Therapies, By Type, 2019–2032 (Usd Million)
Table 50 North America: Epilepsy Market, By End User, 2019–2032 (Usd Million)
Table 51 Us: Epilepsy Market, By Condition, 2019–2032 (Usd Million)